CJC-1295 with DAC (CP10) is a long-acting GHRH analog research peptide used for studies on growth hormone release mechanisms, endocrine regulation, and cell signaling.
CJC-1295 with DAC (CP10) is a modified growth hormone-releasing hormone (GHRH) analog derived from GHRH fragments 1-29, with its stability and research application value enhanced by the DAC (Drug Affinity Complex) structure. This peptide consists of 29 amino acids and is a research-grade growth hormone-releasing peptide. CJC-1295 with DAC is typically supplied as a white to off-white lyophilized powder, and its quality is assessed by HPLC purity analysis and LC-MS identification. It is widely used in research on growth hormone-related molecular mechanisms and endocrine signaling.
CJC-1295 with DAC is primarily used in basic life sciences and endocrinology research, including studies on the GHRH receptor signaling pathway, growth hormone release mechanisms, pituitary cell function, peptide hormone regulation mechanisms, and protein-receptor interactions. Researchers use this peptide as an experimental tool to explore biological processes and their regulatory mechanisms related to the growth hormone axis (GH/IGF-1 pathway).
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Acetate BPC-157 (BC10) is a synthetic polypeptide research compound composed of ...
BPC-157 5mg + TB-500 5mg (BB10) is a compound lyophilized product composed of tw...
BPC-157 10mg + TB-500 10mg (BB20) is a compound research peptide product compose...
Contact our team for volume discounts and custom peptide services